Company intelligence / Profile preview

ImpriMed

Mountain View, California, United Statesimprimedicine.com ↗

Ownership: Private
Employees: ~33
Development stage: Commercial

Overview

ImpriMed has commercialized its AI-powered precision medicine service in veterinary oncology with over 17,000 canine/feline blood cancer tests performed as of mid-2024. The technology has been validated with data from over 5,000 dogs and further validated using large-scale human datasets. Human oncology services are being piloted/validated with initial results presented at major conferences but not yet widely commercialized for humans.

Therapeutic areas: OncologyHematology
Modalities: Artificial intelligence-driven drug response predictionex vivo drug sensitivity assaySmall molecule therapiesBiologic therapies
Industry: Veterinary

Partnerships

Mayo Clinic Platform_Accelerate program for validation studies using large-scale patient databasesAcademic collaborations with Colorado State University College of Veterinary Medicine & Biomedical Sciences and Stanford University School of MedicineSoftBank Ventures Asia-led investor syndicate

Beyond the preview

Go deeper on ImpriMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImpriMed.

Explore the full profile